These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32527190)

  • 1. Differential Use and Impact of Bleeding Avoidance Strategies on Percutaneous Coronary Intervention-Related Bleeding Stratified by Predicted Risk.
    Gluckman TJ; Wang L; Spinelli KJ; Petersen JL; Huang P; Amin A; Messenger JC; Rao SV
    Circ Cardiovasc Interv; 2020 Jun; 13(6):e008702. PubMed ID: 32527190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.
    Vora AN; Peterson ED; McCoy LA; Garratt KN; Kutcher MA; Marso SP; Roe MT; Messenger JC; Rao SV
    JACC Cardiovasc Interv; 2016 Apr; 9(8):771-779. PubMed ID: 27101904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
    Khambatta S; Othman H; Seth M; Lalonde T; Rosman HS; Gurm HS; Mehta RH;
    Cardiovasc Revasc Med; 2016 Jun; 17(4):233-40. PubMed ID: 26994504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A regional pharmacoinvasive PCI strategy incorporating selected bleeding avoidance strategies.
    Chava S; Raza S; El-Haddad MA; Priest J; Ashikaga T; Dauerman HL
    Coron Artery Dis; 2015 Jan; 26(1):30-6. PubMed ID: 25279566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between arterial access site and anticoagulation strategy on major bleeding and mortality: A historical cohort analysis in the Veteran population.
    Bagai J; Little B; Banerjee S
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):95-101. PubMed ID: 28624360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials.
    Shah R; Rogers KC; Ahmed AJ; King BJ; Rao SV
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1313-20. PubMed ID: 27318846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
    Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.
    Leibundgut G; Pache J; Schulz S; Berger PB; Ferenc M; Gick M; Mehilli J; Kastrati A; Neumann FJ
    J Interv Cardiol; 2013 Dec; 26(6):623-9. PubMed ID: 24118114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention.
    Shah R; Jovin IS; Chaudhry A; Haji SA; Askari R; Dennis MM; Berzingi C; Rao SV
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):241-247. PubMed ID: 30269393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Shah R; Matin K; Rogers KC; Rao SV
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):196-204. PubMed ID: 27862911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era: a comparative study.
    Theodos G; Raymond C; Becker MC; Thornton J; Ellis SG; Bhatt DL; Raymond RE
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):294-300. PubMed ID: 22826017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry.
    Washam JB; Kaltenbach LA; Wojdyla DM; Patel MR; Klein AJ; Abbott JD; Rao SV
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005628. PubMed ID: 29432119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Updated Meta-analysis of Radial versus Femoral Access for Percutaneous Coronary Intervention in the Context of Aggressive Bleeding Avoidance Strategies.
    Shah R; Khan S; Rashid A; Siddiqui T; Nayyar M
    Cardiovasc Revasc Med; 2020 Feb; 21(2):242-244. PubMed ID: 31492625
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society.
    Farooq V; Goedhart D; Ludman P; de Belder MA; Harcombe A; El-Omar M;
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27225421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Verdoia M; Barbieri L; Parodi G; Bellandi B; Schaffer A; Suryapranata H; De Luca G
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):553-565. PubMed ID: 28471057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.
    Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Patel D; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28855222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulation.
    Romaguera R; Sardi G; Laynez-Carnicero A; Ben-Dor I; Maluenda G; Wakabayashi K; Hauville C; Torguson R; Xue Z; Kent KM; Satler LF; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2011 Oct; 108(7):932-5. PubMed ID: 21784388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
    Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.